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Abstract
With the second anniversary of Diagnostic Pathology approaching, this Editorial looks at the journal's
achievements so far and outlines the prospects and challenges.
Editorial
Dear Friends, Colleagues, and Authors,
Please allow me to express my deep gratitude for your
interest in and becoming part of our still fairly young
enterprise Diagnostic Pathology. The journal's success so far
encourages me to ask for your continued support for
implementing a high-quality scientific journal covering
the whole range of diagnostic pathology. Our aim is to
provide clinical colleagues and researchers working in
medical diagnostics and therapy with a high-quality,
innovative, and easy-to-handle instrument for the distri-
bution of new insights into tissue-based medical science.
Topics include all aspects of medical information that can
be acquired from human tissue by relevant technologies
such as light or electron microscopy, blood analysis,
polymerase chain reaction methodology, gene analysis,
and data mining, and we also consider descriptions of
individual manifestations of disease.
Our open access, internet-based journal can be read by
anyone at any place of the globe without payment or
other access barriers, the only condition being internet
access. From our point of view this constellation espe-
cially supports colleagues and researchers working at
places or in countries that might experience financial dif-
ficulties in accessing traditional subscription-based jour-
nals.  Diagnostic Pathology, on the other hand, is made
sustainable by author-side charges which can be covered
by research grants, financial support from the rapidly
growing number of institutions welcoming open access,
and institutions' arrangements with BioMed Central as
the journal's publisher. BioMed Central also operates a
waiver policy so as to ensure that publication charges do
not impose new barriers after access barriers have come
down. We fully acknowledge the efforts of authors,
funders, and everyone else involved; we are very grateful
as they really give us the opportunity to promote our jour-
nal Diagnostic Pathology and the unique opportunities it
provides for the rapid and efficient dissemination of
knowledge in our field.
Diagnostic Pathology is coming up to its second anniver-
sary, and we can retrospectively analyze the initial two
years. On average, we had about 70 – 75 submitted arti-
cles per year. At present we can accept about two thirds of
them, with one third being rejected. All in all, an average
of four articles per month is published. Our Editorial
Board of well-known experts works hard to meet the aim
of assuring the scientific quality of submitted articles and
to provide authors with a first response as soon as possi-
ble, often within 14 days after submission. The board con-
sists of active young experts working alongside senior
scientists of international standing. The authors can
expect that their article will be published within two
months or even less, counted from first submission.
Where it takes longer, this is usually due to authors need-
ing more time to revise their papers based on the review-
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ers' recommendations. We would like to take the
opportunity to thank all reviewers for their thorough and
entirely neutral evaluations of submitted articles.
Especially over the last year, the publisher has improved
the tools for the submission and handling of articles, in
close agreement with our suggestions. We are still engaged
in further developing the technical features and to imple-
ment new ideas so as to benefit authors, editors, review-
ers, and readers. Some ideas have been suggested in our
previous Editorial. These included especially a close con-
tact with our readers, whom we encourage to participate
in discussions of and comments on published articles. We
are convinced that this interactive publication model will
be of additional benefit for both authors and readers. The
first step would be an implementation of a discussion
forum associated with already published articles. The next
step under discussion is the implementation of virtual
slides in connection with a specific server. Basically, this
idea will connect science with education and will open a
new chapter in the distribution of medical scientific data.
Several readers (and authors) have asked us about index-
ing coverage of our journal. At present, we are in the eval-
uation process for impact factor tracking by Thomson
Scientific. Also, we are optimistic about meeting the con-
ditions and to be approved for inclusion in Medline in the
near future. However, independent of indexing and track-
ing by external services we can provide our authors and
readers with access data (number of times articles are
viewed). We are proud about the fact that more than seven
articles display more than 300 clicks per months on aver-
age. Several articles have been accessed more than 4000
times since 2006 – and this is only counting accesses to
BioMed Central's server, a figure that would easily double
if downloads from PubMed Central and other freely acces-
sible full-text repositories were added. We can therefore
assure our authors that their articles will be noticed by vast
numbers of researchers, practising clinicians and not least
lay readers (including patients), and that our journal is
already established and recognized by colleagues inter-
ested in our work in the field of diagnostic pathology.
The journal considers a broad range of article types, such
as research, reviews, case reports, methodology articles,
debates, or hypotheses. A high percentage of the articles
published is made up of case reports, most of them with
very rare diseases or disease constellations. We believe
that case reports are still of scientific and educational
value, even – or especially – in the time of electronic com-
munication and evidence-based learning. Usually, at least
half of the most-viewedarticles are case reports, vindicat-
ing the value of case reports for the community. Keeping
the balance right between scientific quality, medical inter-
est, and working conditions of authors who want to dem-
onstrate their experience and expertise is a major factor in
building a successful scientific journal such as Diagnostic
Pathology. This duty has been successfully supported by all
members of the Editorial Board, and my special gratitude
goes to Dr. Torsten Goldmann and Dr. Gian Kayser. In
addition, Diagnostic Pathology has been excellently assisted
by the editorial staff at Biomed Central, especially by Ste-
fan Busch and his colleagues whom I thank very much for
all their efforts.
Dear authors and readers, let us work together to further
improve Diagnostic Pathology with the aim to create an
increasingly attractive, innovative and cutting-edge online
publication for the benefit of the community.
I wish all our readers, authors, interested scientists, and
members of our Editorial Board a Happy, Healthy and
Prosperous New Year 2008.
Berlin, December 2007
Klaus Kayser M.D., Ph.D.
Editor-in-Chief.